Somatropin has been FDA-approved since 1985 (recombinant form)
Studies show GH plays a major role in reducing visceral fatthe dangerous belly fat linked to metabolic disease
Its fascinating to note that our bodies produce this vital compound, yet the levels of glutathione can significantly decline as we age or are exposed to environmental toxins
Given that chronic hepatitis and cirrhosis are major risk factors for HCC, the anti-inflammatory and anti-fibrotic effects of L-carnitine could theoretically contribute to reduced HCC risk in patients with advanced MASLD, but this hypothesis awaits clinical validation
Epidemiology, treatment patterns, and clinical outcomes in de novo oligometastatic hormone-sensitive prostate cancer
Resources on maintaining weight loss after tirzepatide , managing semaglutide discontinuation , and the tirzepatide tapering process support the transition from active loss to maintenance effectively